Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Additive diagnostic value of prostate specific membrane antigen (PSMA) positron emission tomography (PET) to multiparametric magnetic resonance imaging (mpMRI) in the diagnostic setting: Ability to reduce unnecessary prostate biopsies in men being investigated for prostate cancer.

Next Previous
X
Search
Trial Profile

Additive diagnostic value of prostate specific membrane antigen (PSMA) positron emission tomography (PET) to multiparametric magnetic resonance imaging (mpMRI) in the diagnostic setting: Ability to reduce unnecessary prostate biopsies in men being investigated for prostate cancer.

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 16 Nov 2022

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Gallium (68Ga) gozetotide (Primary)
  • Indications Prostate cancer
  • Focus Diagnostic use
  • Acronyms PRIMARY

    • Most Recent Events

    • 13 Nov 2022 Results of retrospective analysis (n=100) to identify synchronous reading of multiparametric MRI (mpMRI) and 68Ga-PSMA-11 PET/CT (PSMA-PET) images can improve diagnostic performance and certainty against mpMRI/PSMA-PET reported independently and synthesized, while also assessing concordance between imaging modalities and agreement with histopathology from the PRIMARY trial, published in the BJU International.
    • 18 Jul 2019 Planned initiation date changed from 29 Oct 2018 to 19 Jul 2019.
    • 18 Jul 2019 Planned End Date changed from 15 Apr 2019 to 30 Jun 2020.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top